Lumos Diagnostics Holdings Ltd (LDX) — Capital Reinvestment Ratio
Latest as of December 2025:
0.24x
Lumos Diagnostics Holdings Ltd (LDX) has a Capital Reinvestment Ratio of 0.24x as of December 2025, meaning it reinvests 0% of its operating cash flow (AU$778.03K) in capital expenditures (AU$189.41K). See LDX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.24x
Capex / Operating Cash Flow
Operating Cash Flow
AU$778.03K
AUD
Capital Expenditures
AU$189.41K
AUD
Data as of
Dec 2025
Most recent filing
Lumos Diagnostics Holdings Ltd Capital Reinvestment Ratio (2023–2023)
This chart tracks Lumos Diagnostics Holdings Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Lumos Diagnostics Holdings Ltd (2023–2023)
Year-by-year Capital Reinvestment Ratio for Lumos Diagnostics Holdings Ltd from 2023 to 2023. For live market cap and broader valuation context, see LDX stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.10x | AU$946.00K | AU$98.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow